Considerations for dedicated and campaigned use
Read MorePeter Walters
Director of ATMPs
San Diego, CA

Peter Walters is a process engineer with 15 years of experience specializing in pharmaceutical process and facility design. He has designed equipment and processes for the multi-step manufacturing of pharmaceutical drug products, performed scale up of aseptic bulk process to various capacities and product manufacturing for clinical studies in phases I, II and III. His experience includes the design, development and validation of clean-in-place and sanitize-in-place processes for aseptic bulk production systems. Peter has extensive experience with CGMP manufacturing, including generation of procedures and batch records, validation of systems and processes and the manufacture of clinical and commercial products.
His expertise includes experimental design, process characterization, equipment and process troubleshooting and manufacturing for clinical phase I through commercial production. He is well versed in production performance and process and product analysis. He has designed process facilities for monoclonal antibodies, gene therapies, autologous and allogeneic cell therapies and aseptic novel processes, in both stainless steel and single-use equipment. He has helped author a New Drug Application and has participated in Food and Drug Administration facility inspections. He is a co-inventor for a patented novel product formulation process. Peter was recognized by Consulting-Specifying Engineer with the 40 Under 40 award in 2018.
Throughout his career, Peter has taken a particular interest in opportunities for creativity. With his commissioning and pilot-scale experience, he has a strong talent for understanding equipment use and troubleshooting.
Peter graduated from the University of California, Davis with a degree in chemical/biochemical engineering. He is a Southern California native and enjoys playing soccer and spending time with his family in San Diego.
Insights By Peter

The future of cell and gene therapy
The future of cell and gene therapy and defending our global population from disease—those we know and those to come—requires new nimbleness for development and manufacturing.
Read More
Multimodal manufacturing—avoid challenges in the ATMP marketplace
Multimodal manufacturing facilities are designed to balance the efficiencies of a standardized and modular cleanroom template with just enough configurability to suit unique operator needs. As a result, they’re becoming known as a modern, cost-effective, highly flexible solution to the present-day challenges and future needs of ATMP manufacturing.
Read More
Multimodal manufacturing — what’s your perfect fit?
Here’s the thing we figured out about offering a single solution, though: when you try to fit everyone, you wind up fitting no one. That’s how we got where we are today, with three distinct SlateXpace models. Clients can deploy just one, or mix and match them to create a near-infinite array of combinations, suitable for different needs or phases of growth.
Read More
Viral vectors—beyond the yellow brick road
Listen to the webinar to achieve a more fulsome appreciation of the interdependent factors that contribute to an efficient and reliable throughput of viral vector products at a commercial scale.
Read More